Moderna
MRNA
#1173
Rank
A$24.77 B
Marketcap
$64.39
Share price
1.76%
Change (1 day)
-53.85%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$24.77 Billion

As of December 2024 Moderna has a market cap of A$24.77 Billion. This makes Moderna the world's 1173th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024A$24.77 B-55.48%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Moderna was reported to be:

A$24.34 Billion
by Yahoo Finance info icon info icon
A$24.34 Billion
by CompaniesMarketCap info icon info icon
A$24.34 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.16 B-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$400.41 B 1,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.33 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.82 B 101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$312.61 B 1,161.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.91 B-84.18%๐Ÿ‡บ๐Ÿ‡ธ USA
A$557.26 B 2,148.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.78 B-80.70%๐Ÿ‡บ๐Ÿ‡ธ USA